Brown Brothers Harriman & Co’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-60
Closed -$3.44K 1883
2025
Q3
$3.44K Hold
60
﹤0.01% 1493
2025
Q2
$3.54K Buy
+60
New +$3.88K ﹤0.01% 1323
2025
Q1
Sell
-33
Closed -$2.73K 1370
2024
Q4
$2.73K Hold
33
﹤0.01% 1308
2024
Q3
$2.36K Buy
+33
New +$2.33K ﹤0.01% 1280

Other funds holding GMED

Brown Brothers Harriman & Co's GMED Position: Q4 2025 in Review

Brown Brothers Harriman & Co sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 60 shares — an estimated $3.44K sold.

Brown Brothers Harriman & Co first reported a position in GMED in Q3 2024 and held it in 4 quarters. The position peaked at $3.54K in Q2 2025. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Brown Brothers Harriman & Co reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 60 Globus Medical shares in Q4 2025, an estimated $3.44K.
  • Brown Brothers Harriman & Co first reported a position in Globus Medical in Q3 2024 and held it in 4 quarters.
  • Brown Brothers Harriman & Co's Globus Medical position peaked at $3.54K in Q2 2025.
  • 563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2025, filed 12 Feb 2026.